We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.3B
AUM Growth
-$819M
(-5.4%)
Cap. Flow
-$4.1B
Cap. Flow
% of AUM
-28.74%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
669
New
46
Increased
230
Reduced
138
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$90.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$64M |
| 3 |
Newell Brands
NWL
|
+$49.9M |
| 4 |
Baxter International
BAX
|
+$49.1M |
| 5 |
Visa
V
|
+$47.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$85.5M |
| 2 |
Walt Disney
DIS
|
+$78.1M |
| 3 |
AbbVie
ABBV
|
+$69.4M |
| 4 |
HCA Healthcare
HCA
|
+$65.8M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.59% |
| 2 | Technology | 9.91% |
| 3 | Communication Services | 8.97% |
| 4 | Industrials | 8.5% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZLTQ
151
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $19M | 0.13% |
696,038
+675,913
| +3,359% | +$19M |
|
152
Tesla
TSLA
$1.24T
| $18.9M | 0.13% |
1,338,030
-1,214,340
| -48% | -$18.4M |
|
153
Expedia Group
EXPE
$31.2B
| $18.9M | 0.13% |
+178,011
| New | +$19.3M |
|
|
FRC
154
DELISTED
First Republic Bank
FRC
| $18.8M | 0.13% |
268,500
| – | – |
|
155
Walmart Inc
WMT
$871B
| $18.2M | 0.13% |
746,586
+231
| +0% | +$5.35K |
|
156
IBM
IBM
$202B
| $16.9M | 0.12% |
116,633
-1,004
| -0.9% | -$144K |
|
157
Cisco
CSCO
$450B
| $16.9M | 0.12% |
588,013
+200
| +0% | +$5.61K |
|
158
Jazz Pharmaceuticals
JAZZ
$15.9B
| $16.8M | 0.12% |
119,104
-69,941
| -37% | -$10.3M |
|
159
TJX Companies
TJX
$170B
| $15.9M | 0.11% |
410,748
+26
| +0% | +$992 |
|
160
Biogen
BIIB
$29.9B
| $15.7M | 0.11% |
64,908
-18
| -0% | -$4.74K |
|
161
CVS Health
CVS
$137B
| $15.7M | 0.11% |
163,506
+60
| +0% | +$5.98K |
|
162
Oracle
ORCL
$331B
| $15.6M | 0.11% |
381,983
-735,067
| -66% | -$29.4M |
|
|
AA.PRB
163
DELISTED
Alcoa Inc
AA.PRB
| $15.6M | 0.11% |
473,069
-2,922
| -0.6% | -$99.3K |
|
164
Booking.com
BKNG
$138B
| $15.4M | 0.11% |
308,675
-72,700
| -19% | -$3.77M |
|
165
Ford
F
$57.3B
| $14.9M | 0.1% |
1,187,102
-9,239
| -0.8% | -$122K |
|
166
Amgen
AMGN
$203B
| $14.5M | 0.1% |
95,387
+30
| +0% | +$4.66K |
|
167
Liberty Global Class A
LBTYA
$3.28B
| $14M | 0.1% |
481,840
-1,039,190
| -68% | -$33.7M |
|
|
PAY
168
DELISTED
Verifone Systems Inc
PAY
| $13.9M | 0.1% |
747,624
-675,653
| -47% | -$17.1M |
|
|
DD
169
DELISTED
Du Pont De Nemours E I
DD
| $13.8M | 0.1% |
213,656
-1,865
| -0.9% | -$122K |
|
170
Whirlpool
WHR
$2.42B
| $12.9M | 0.09% |
77,133
+3
| +0% | +$529 |
|
171
Carnival Corporation Ltd
CCL
$36.1B
| $12.8M | 0.09% |
288,735
+25
| +0% | +$1.23K |
|
172
Nokia
NOK
$50.8B
| $12.5M | 0.09% |
2,200,000
| – | – |
|
173
Duke Energy
DUK
$102B
| $12.5M | 0.09% |
145,737
+53
| +0% | +$4.24K |
|
|
SRCLP
174
DELISTED
Stericycle, Inc
SRCLP
| $12.5M | 0.09% |
150,000
| – | – |
|
175
Thermo Fisher Scientific
TMO
$211B
| $12.4M | 0.09% |
84,006
-25,369
| -23% | -$3.74M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, Calamos Advisors held 669 positions worth $14.3B, down 5.4% from $15.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Calamos Advisors withdrew a net $4.1B in Q2 2016, closing 57 positions and reducing 138 holdings. Its most notable exit was HCA Healthcare, an estimated $65.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Calamos Advisors opened a new position in Newell Brands worth $51.9M.
- Calamos Advisors's largest Q2 2016 buy was Newell Brands: 1,068,110 shares worth $51.9M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $90.5M increase.
- Calamos Advisors's biggest Q2 2016 reduction was Accenture, cutting an estimated $85.5M.
- Calamos Advisors fully exited HCA Healthcare in Q2 2016, selling an estimated $65.8M.
- Calamos Advisors's ten largest holdings make up 17% of its $14.3B portfolio in Q2 2016.
- Calamos Advisors opened 46 new positions and closed 57 in Q2 2016.
- Calamos Advisors's portfolio value fell 5.4% quarter-over-quarter to $14.3B.
Based on Calamos Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.